Kynmobi

Apomorphine Hydrochloride Hemihydrate, the active ingredient in Kynmobi, is a dopamine agonist presented as a sublingual formulation for sublingual use. It is employed to manage OFF episodes in patients with Parkinson's disease, helping to restore motor function during periods of reduced dopaminergic activity.

GNH USA supplies Kynmobi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand, including export to EU and Asian markets.

Kynmobi is a dopamine agonist used within the Parkinson's disease therapeutic pathway to improve motor control.

- OFF episodes in Parkinson's disease: restores motor function during periods of reduced dopaminergic activity. - Motor fluctuations in Parkinson's disease: helps smooth transitions between ON and OFF states. - Adjunct therapy in Parkinson's disease: used alongside levodopa to enhance overall symptom control.

Apomorphine may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea - Dizziness - Headache - Orthostatic hypotension - Somnolence - Dry mouth

Serious or Rare Side Effects: - Severe hypotension or syncope - Hallucinations or psychosis - Impulse control disorders - Severe nausea or vomiting - Allergic reactions including rash or anaphylaxis - Cardiac arrhythmias

When prescribing apomorphine, clinicians should observe several safety measures.

- Dose titration: start low and increase gradually as directed by the prescriber. - Orthostatic hypotension: monitor blood pressure when changing positions. - Nausea management: consider antiemetic pre‑treatment if needed. - Psychiatric effects: watch for hallucinations, mood changes, or impulse control issues. - Contraindications: avoid in patients with known hypersensitivity to apomorphine. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Apomorphine can interact with other medicines, requiring careful assessment.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Dopamine antagonists (e.g., antipsychotics): may block therapeutic effect.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive hypotensive effect. - Antiemetics such as metoclopramide: may increase dopaminergic activity. - Alcohol: may enhance dizziness and sedation.